NewTradingView.com
Investing and Stock News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Investing

SK Hynix stock jumps 11% after historic rout: is the worst now over?

by July 15, 2026
written by July 15, 2026

SK Hynix stock jumped 11% in Seoul on Wednesday, extending a rapid rebound from the worst single-day decline in the chipmaker’s history.

The recovery follows extraordinary whiplash around its Nasdaq listing.

SK Hynix’s American depositary receipts gained 12.8% in their Friday debut, before the Korean shares crashed 15.4% on Monday as investors locked in profits.

A tentative 3.7% recovery on Tuesday was followed by Wednesday’s stronger advance, suggesting some investors believe the recent rout went too far.

SK Hynix stock: From record crash to sharp comeback

SK Hynix’s ADRs were priced at $149, opened at $170 and closed their first Nasdaq session at $168.01.

The blockbuster listing raised about $26.5 billion, setting a record for a US share sale by a foreign company.

That enthusiasm quickly collided with profit-taking, leveraged positioning and a wider sell-off in South Korean stocks.

Monday’s decline helped drag the Kospi down about 9%, triggering a temporary market-wide trading halt.

Leveraged funds linked to SK Hynix amplified the reversal as investors rushed to cut exposure.

The mood improved after softer US inflation data revived demand for technology shares.

SK Hynix rose as much as 13% on Wednesday before trimming the gain, while Samsung Electronics advanced about 6%.

Hanmi Semiconductor, a supplier of chip-packaging equipment, surged roughly 25% in early trade.

The rebound also followed a strong US session for memory stocks.

SK Hynix’s ADRs soared almost 28% on Tuesday after Barclays began coverage with an Overweight rating and a $330 target.

Micron and other semiconductor names also advanced, reinforcing the view that Monday’s rout was driven in part by positioning rather than by a sudden deterioration in AI demand.

Why analysts say the selling was overdone

Phillip Wool, chief research officer at Rayliant Global Advisors, told CNBC that the weakness in Asian AI hardware stocks was “mostly risk management”.

Investors had built unusually large positions in South Korean and Taiwanese chipmakers following their exceptional rallies, Wool said.

Reducing those holdings represented prudent portfolio rebalancing rather than a loss of enthusiasm for AI infrastructure.

Daniel Yoo, global strategist at Yuanta Securities, told CNBC’s Squawk Box Asia that investors were still trying to determine the appropriate valuation after the ADR issuance created a new US benchmark for SK Hynix.

The additional supply and the unusually large premium between the ADRs and Korean shares have contributed to short-term volatility.

UBS has retained a Buy rating and raised its Korean-share price target to 3.2 million won.

The bank expects operating profit of 327 trillion won in 2026, roughly 27% above market consensus, supported by HBM4 shipments, longer-term customer agreements and potential shareholder returns following the US listing.

Not everyone is convinced the rally has legs

The recovery does not erase the risks created by SK Hynix’s remarkable run.

Even after the correction, the Korean shares remain several times higher than they were a year ago, an unusual performance for an industry historically defined by sharp cycles of shortage and oversupply.

Investment writer Edward Sheldon argued in a bear-case analysis published by Themes ETFs that investors may be underestimating memory cyclicality, rising competition and SK Hynix’s dependence on a small number of major AI customers.

Morningstar is similarly cautious. Analyst Lorraine Tan said the current memory upcycle was proving stronger than expected, but maintained that conditions would eventually normalise, limiting the potential upside at elevated prices.

The research firm valued the ADRs at $160 before their latest surge.

The post SK Hynix stock jumps 11% after historic rout: is the worst now over? appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Hang Seng jumps as healthcare and biotech stocks rally despite weak China GDP data
next post
Kospi rockets 7% as US inflation shock unleashes Asia-wide rally

You may also like

Amazon stock is struggling: will upcoming earnings ignite...

July 17, 2026

UK stocks steady as rising oil prices lift...

July 17, 2026

Looking to diversify away from AI trade? Buy...

July 17, 2026

Intuitive Surgical stock sinks despite earnings beat on...

July 17, 2026

Kimi K3 explained: Inside Moonshot’s biggest open AI...

July 17, 2026

Dow futures plunge 360 points: 5 things to...

July 17, 2026

Volvo Group reports higher Q2 earnings, lifts truck...

July 17, 2026

Top FTSE 100 Index shares to watch next...

July 17, 2026

Burberry share price has dipped after earnings: what...

July 17, 2026

SpaceX stock slips further after Starship test flight...

July 17, 2026
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!




    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Popular Posts

    • 1

      Bitcoin Rebounds to $83,404 Amid Renewed Investor Confidence

    • 2

      Gold Price Surge Hits $3,385 Amid Trade Tensions

    • 3

      Kraken Rolls Out Commission-Free Stock Trading

    • 4

      Buy Bitcoin Under $100K Before The Next Bull Run

    • 5

      BNB Price Surge Leads Crypto Gains as Bitcoin Climbs

    Recent Posts

    • Amazon stock is struggling: will upcoming earnings ignite a comeback?

      July 17, 2026
    • UK stocks steady as rising oil prices lift energy shares amid Middle East tensions

      July 17, 2026
    • Looking to diversify away from AI trade? Buy these 3 stocks

      July 17, 2026
    • Intuitive Surgical stock sinks despite earnings beat on 2026 procedure growth outlook

      July 17, 2026
    • Kimi K3 explained: Inside Moonshot’s biggest open AI bet yet

      July 17, 2026

    Categories

    • Economy (20)
    • Editor's Pick (178)
    • Investing (671)
    • Stock (31)
    • Terms and Conditions
    • Privacy Policy

    Copyright © 2026 newtradingview.com | All Rights Reserved


    Back To Top
    NewTradingView.com
    • Investing
    • Stock
    • Economy
    • Editor’s Pick